HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2187971Generated: October 30, 2026
Imidazole → N-Boc-5-Iodo-D-norvaline tert-butyl ester
https://huagongshe.com/reaction/2187971
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Iodine | HCID 807 | — |
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | tert-butyl (2R)-2-{[(tert-butoxy)carbonyl]amino}-5-hydroxypentanoate | HCID 15814357 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | N-Boc-5-Iodo-D-norvaline tert-butyl ester | HCID 15479355 | 72% |
Reaction Steps
A solution of the title E compound, (2R)-(t-butyioxycarbonylamino)-5-hydroxy-pentanoic acid t-butyl ester (9.12 g, 31.5 mmol), imidazole (3.22 g, 47.3 mmol) and triphenylphosphine (12.40 g, 47.3 mmol) in 300 mL of THF is treated portionwise over 5 min with iodine (9.60 g, 37.8 mmol) at RT. After 2 h, the mixture is filtered and concentrated. The residue is first filtrated though silica gel (eluant; ethyl acetate) then purified by chomatography on silica gel (eluant; 10% ethyl acetate in hexane) affording 9.05 g (72%) of (2R)-(t-butyloxycarbonylamino)-5-iodopentanoic acid t-butyl ester as a colorless oil: NMR(CDCl3) 1.42 (s, 9H), 1.46 (s, 9H), 1.65-1.95 (m, 4H), 3.14-3.28 (m, 2H), 4.19-4.26 (m, 1H), 5.06 (br d, 1H, J=7.4); IR 1712, 1500, 1155; ESI-MS 400 (M++1).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06410580B1 |
|---|
| Source dataset | uspto-grants-2002_06 |
|---|
| ORD ID | ord-69037a82ce6d4a0c89bff5844f055efa |
|---|
| Source note | uspto-grants-2002_06 |
|---|